超声波处理会影响不同溶剂中的兰的宏分子,形状,结构和质性质
Tong-Xin Liang1, Le-Yi Pan1, Peiwen Long1
1Dongguan Key Laboratory of Typical Food Precision Design, China National Light Industry Key Laboratory of Healthy Food Development and Nutrition Regulation, School of Life and Health Technology, Dongguan University of Technology, Dongguan 523808, China.
Ultrasonics sonochemistry
|February 28, 2025
概括
在DMSO中进行超声波处理可以增强纹.
科学领域:
- 生物聚合物科学 生物聚合物科学
- 材料科学 材料科学 材料科学
- 食品科学 食品科学 食品科学
背景情况:
- 库德兰是一种微生物多糖,由于结合,其水溶性有限.
- 溶剂的选择影响了Curdlan的链形状和特性.
- 了解修改效应是工业应用的关键.
研究的目的:
- 为了研究超声波对Curdlan的宏分子,结构和质性质的影响.
- 为了比较三个不同的溶剂的这些效应:NaOH,DMSO和中和 (AN).
- 为了建立一个基础,优化curdlan修改.
主要方法:
- 库德兰在0.1M NaOH,DMSO和AN溶液中接受了60分钟的超声波处理.
- 分析了水溶性,分子量,形状和质性质.
- 使用光谱和物理方法来描述变化.
主要成果:
- 与NaOH和AN相比,在DMSO中的超声波显著增加了curdlan的水溶性 (16.26%) 并降低了其分子量 (10.53 kDa).
- DMSO促进了键的断裂,改变了Curdlan的形状,从柔性链到不规则的螺旋.
- 超声波治疗通常会降低Curdlan的质性质.
结论:
- DMSO是用于超声波修饰的首选溶剂,增强溶解性和改变结构.
- 超声波降解在柔性链上比刚性棒更有效.
- 研究结果支持使用超声波修饰来扩大库德兰在食品和生物医学中的应用.
相关概念视频
Factors Affecting Solubility
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
Variables Affecting Phosphorescence and Fluorescence
Fluorescence and phosphorescence are essential phenomena in fields like analytical chemistry, biological imaging, and materials science, where they detect molecular properties and visualize cellular structures. Understanding the variables that influence these luminescent behaviors is crucial for maximizing accuracy and efficiency in their applications. These variables can broadly be grouped into chemical structure, solvent properties, and external conditions, each playing a distinct role in...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Factors Affecting Drug Distribution: Tissue Permeability
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...


